| Description | Gavilimomab (ABX-CBL), an IgM murine monoclonal antibody, targets CD147 on cell surfaces to induce complement-mediated cytotoxicity. It is utilized in the study of graft-versus-host disease (GVHD) [1]. |
| Synonyms | ABX-CBL |
| molecular weight | N/A |
| CAS | 244096-20-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |